Retroviral Surface Display for Targeted Gene Delivery and Cell Screening
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for screening cells, particularly T cells, for specific antigens and delivering nucleic acids to target cells are inefficient and require significant effort, with previous approaches being limited by the need for recombinant expression of T cell receptors and low throughput.
Innovation Solution
Retroviruses are engineered with mutated envelope proteins and non-viral membrane-bound proteins with extracellular targeting domains to enable specific entry into target cells, allowing for high-throughput screening and targeted nucleic acid delivery without recombinant TCR expression.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Speed
If retroviruses are pseudotyped with wild-type envelope proteins for efficient entry, then viral entry efficiency is improved, but target cell specificity deteriorates
Solution Approach 1:
The patent applies local quality by creating heterogeneous envelope protein compositions on the viral surface. The retrovirus displays both wild-type envelope proteins (for efficient entry) and mutated envelope proteins with diminished native function (for specificity). This local differentiation allows different regions of the viral surface to perform different functions: wild-type proteins facilitate rapid membrane fusion and entry, while mutated proteins provide selective binding to target cell receptors, thereby resolving the contradiction between entry efficiency and target specificity.
Solution Approach 2:
The patent employs composite materials by combining multiple types of envelope proteins in a single viral particle. The envelope is composed of a mixture of wild-type envelope proteins (maintaining high entry efficiency) and mutated envelope proteins (providing target cell specificity through diminished native function). This composite envelope structure allows the virus to simultaneously achieve both rapid entry and selective targeting, resolving the technical contradiction between these two opposing requirements.
2Measurement precision
If recombinant TCR expression is used for antigen-specific screening, then screening specificity is improved, but device complexity and throughput deteriorate
Solution Approach 1:
The patent applies the taking out principle by extracting the T cell recognition function from the complex recombinant TCR expression system and transferring it to the retroviral envelope proteins. Instead of requiring full TCR recombinant expression in target cells, the system uses simplified envelope proteins that directly mediate antigen-specific binding and viral entry. This extraction eliminates the need for complex TCR expression machinery while maintaining antigen-specific screening capability, thereby reducing device complexity without sacrificing specificity.
Solution Approach 2:
The patent applies copying by creating simplified copies of the T cell antigen recognition function. Rather than using the full complexity of recombinant TCR-expressing T cells, the system uses retroviral envelope proteins that copy the essential antigen-binding function. These envelope protein copies can be easily produced and screened, maintaining the ability to identify antigen-specific cells while dramatically simplifying the overall system and enabling high-throughput applications.
3Measurement precision
If mutated envelope proteins with diminished native function are used, then target cell specificity is improved, but viral entry efficiency deteriorates
Solution Approach 1:
The patent applies merging by combining mutated envelope proteins (providing target specificity) with wild-type envelope proteins (providing entry efficiency) in the same viral particle. The mutated envelope proteins ensure selective binding to target cell receptors, while the co-expressed wild-type envelope proteins compensate for any loss in fusion efficiency. This merging of different envelope protein types allows the virus to simultaneously achieve both high target cell specificity and maintained viral entry efficiency, resolving the contradiction between these two parameters.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables high-throughput screening of cells for specific antigens and targeted nucleic acid delivery, overcoming limitations of previous methods by allowing screening of >10^8 ligands without recombinant TCR expression, and achieving precise targeting of cells like T cells.
Implementation Method 1
pseudotyping with the VSV glycoprotein, which targets the LDL receptor and therefore enables viral entry into a wide range of cells
Data Source
AI summary
Compositions of retroviruses and methods of using the same for gene delivery are disclosed, wherein the retroviruses comprise a viral envelope protein comprising at least one mutation that diminishes its native function, a non-viral membrane-bound protein comprising a membrane-bound domain and an extracellular targeting domain.